Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida Albicans

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Dhamgaye, Sanjiveeni ^a   Devaux, Frédéric ^b   Vandeputte, Patrick ^c   Khandelwal, Nitesh Kumar ^a   Sanglard, Dominique ^c   Mukhopadhyay, Gauranga ^a   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CALCINEURIN; ERGOSTEROL; HEAT SHOCK TRANSCRIPTION FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; ANTIFUNGAL AGENT; FUNGAL PROTEIN; HEAT SHOCK PROTEIN; TRANSCRIPTION FACTOR;

ANTIFUNGAL ACTIVITY; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CARBON SOURCE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; DRUG TRANSPORT; FUNGAL CELL WALL; FUNGAL STRAIN; LIPOGENESIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTANT; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE ACCLIMATIZATION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANTIFUNGAL RESISTANCE; CANDIDIASIS; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION;

ANTIFUNGAL AGENTS; BERBERINE; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE; FUNGAL PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; MUTATION; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 84905638763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104554     Document Type: Article

References (47)

1. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, et al. (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42:1519-1527. (Pubitemid 38500790)
2. Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, et al. (2003) Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 47:3149-3154. (Pubitemid 37229571)
3. Odds FC, Brown AJ, Gow NA (2003) Antifungal agents: mechanisms of action. Trends in Microbiology 11:272-279. (Pubitemid 36725017)
4. Warrilow AG, Martel CM, Parker JE, Melo N, Lamb DC, et al. (2010) Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51). Antimicrob Agents Chemother 54:4235-45.
5. Sucher AJ, Chahine EB, Balcer HE (2009) Echinocandins: the newest class of antifungals. Ann Pharmacother 43:1647-57.
6. Ellis D (2002) Amphotericin B: spectrum and resistance. J Antimicrob Chemother 49:7-10
7. Ghannoum MA, Louis B (1999) Rice3 Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance Clin Microbiol Rev 12: 501-517.
8. White TC, Marr KA, Bowden RA (1998) Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clin Microbiol Rev 11:382-402. (Pubitemid 28197359)
9. Zhang H, Gao A, Li F, Zhang G, Ho HI, et al. (2009) Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps. Yakugaku Zasshi 129:623-630.
10. Martins CV, da Silva DL, Neres AT, Magalhaes TF, Watanabe GA, et al. (2009) Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother 63:337-339.
11. Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, et al. (2009) Curcumin Modulates Efflux Mediated by Yeast ABC Multidrug Transporters and Is Synergistic with Antifungals. Antimicrob Agents Chemother 53:3256-3265.
12. Gomes-de-Elvas AR, Palmeira-de-Oliveira A, Gaspar C, Gouveia P, Palmeira-de-Oliveira R, et al. (2012) In vitro assessment of gentian violet anti- candida activity. J Gynecol Obstet Invest 74:120-4.
13. Steverding D, Evans P, Msika L, Riley B, Wallington J, et al. (2012) In vitro antifungal activity of DNA topoisomerase inhibitors. Med Mycol 50:333-6
14. Binder U, Oberparleiter C, Meyer V, Marx F (2010) The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. Mol Microbiol 75: 294-307.
15. Dhamgaye S, Devaux F, Manoharlal R, Vandeputte P, Shah AH, et al. (2012) In Vitro Effect of Malachite Green on Candida albicans Involves Multiple Pathways and Transcriptional Regulators UPC2 and STP2. Antimicrob Agents Chemother 56: 495-506.
16. Tan W, Li Y, Chen M, Wang Y (2011) Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomedicine 6:1773-7.
17. Birdsall TC, Kelly GS (1997) Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2:94-103. (Pubitemid 127735667)
18. Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB, et al. (2010) In vitro antifungal activity of the berberine and its synergism with fluconazole. Antonie van Leeuwenhoek 97:201-205.
19. Nicholls S, Leach MD, Priest CL, Brown AJ (2009) Role of the heat shock transcription factor, Hsf1, in a major fungal pathogen that is obligately associated with warm-blooded animals. Molecular Microbiol 74:844-861.
20. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition. CLSI document M27-A3 (ISBN 1-56238-666-2). Clinical and Laboratory Standards Institute, Wayne, Pennsylvania 19087-1898 USA.
21. Mukhopadhyay K, Kohli AK, Prasad R (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents and Chemother 46:3695-3705. (Pubitemid 35403239)
22. Bauer C, Herzog V, Bauer MF (2001) Improved technique for electron microscope visualization of yeast membrane structure. Microsc Microanal 7:530-534.
23. Li DD, Xu Y, Zhang DZ, Quan H, Mylonakis E, et al. (2013) Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Antimicrob Agents Chemother 57:6016-27.
24. Menezes RA, Amaral C, Batista-Nascimento L, Santos C, Ferreira RB, et al. (2008) Contribution of Yap1 towards Saccharomyces cerevisiae adaptation to arsenic-mediated oxidative stress. Biochem J 414:301-311.
25. Bambach A, Fernandes MP, Ghosh, Kruppa M, Alex D, et al. (2009) Goa1p of Candida albicans Localizes to the Mitochondria during Stress and Is Required for Mitochondrial Function and Virulence. Eukaryot Cell 8:1706-1720.
26. Jantová S, Cipák L, Cernáková M, Kost'álová D (2003) Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 55:1143-9.
27. Morschhäuser J (2010) Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47:94-106.
28. Franz RS, Kelly L, Lamb DC, Kelly DE, Ruhnke M, et al. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42:3065-3072. (Pubitemid 28553719)
29. Franz R, Ruhnke M, Morschhauser J (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458. (Pubitemid 29470386)
30. Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP (2002) Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162:1573-81. (Pubitemid 36114647)
31. Bossche HV (1997) Mechanisms of antifungal resistance. Rev Iberoam Micol 14: 44-49
32. Letscher-Bru V, Herbrecht R (2003) Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51:513-21. (Pubitemid 36336143)
33. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3:1639-52 (Pubitemid 40025121)
34. Znaidi S, Weber S, Al-Abdin OZ, Bomme P, Saidane S, et al. (2008) Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell 7:836-47. (Pubitemid 351968827)
35. Kumar A, Dhamgaye S, Maurya IK, Singh A, Sharma M, et al. (2014) Curcumin targets cell wall integrity via calcineurin mediated signaling in Candida albicans. Antimicrob Agents Chemother 58:167-75.
36. Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, et al. (2002) Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21:546-59. (Pubitemid 34174036)
37. Blokhina O, Virolainen E, Fagerstedt KV (2003) Antioxidants, Oxidative Damage and Oxygen Deprivation Stress: a Review. Ann Bot 91: 179-194.
38. Meeran SM, Katiyar S, Katiyar SK (2008) Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229:33-43.
39. Lin CC, Yang JS, Chen JT, Fan S, Yu FS, et al. (2007) Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 27:3371-8. (Pubitemid 47607564)
40. Pereira GC, Branco AF, Matos JAC, Pereira SL, et al. (2007) Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions. J Pharmacol Exp Ther 323:636-49. (Pubitemid 350005145)
41. Chauhan N, Calderone R (2008) Two-component signal transduction proteins as potential drug targets in medically important fungi. Infection and Immunity 76:4795-4803.
42. Hameed S, Dhamgaye S, Singh A, Goswami SK, Prasad R (2011) Calcineurin Signaling and Membrane Lipid Homeostasis Regulates Iron Mediated MultiDrug Resistance Mechanisms in Candida albicans. PLoS ONE 6(4): e18684.
43. Ferrari S, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, et al. (2011) Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother 55:1852-60.
44. Sun N, Fonzi W, Chen H, She X, Zhang L, et al. (2013) Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Antimicrob Agents Chemother 57:532-42.
45. Singh A, Yadav V, Prasad R (2012) Comparative Lipidomics in Clinical Isolates of Candida albicans Reveal Crosstalk between Mitochondria, Cell Wall Integrity and Azole Resistance. PLoS ONE 7(6): e39812.
46. Prasad R, Singh A (2013) Lipids of Candida albicans and their role in multidrug resistance. Current Genetics 59:243-250.
47. Dhamgaye S, Bernard M, Lelandais G, Sismeiro O, Lemoine S, et al. (2012) RNA sequencing revealed novel actors of the acquisition of drug resistance in Candida albicans. BMC Genomics 13:396.